Academic Honors & Events

Search Academic Honors & Events


Dedication to Graduate Programs—The National Association for Graduate Admissions Professionals (NAGAP) presented Salvatore Calabro with its inaugural Chapter Leader Award at their annual conference in New Orleans, LA. This award recognizes Mr. Calabro’s accomplishments in growing NAGAP, the sole professional organization dedicated solely to supporting and empowering graduate enrollment workers. Mr. Calabro co-founded and served as the first president of Biomedical Sciences Association of Graduate Admissions Professionals (BIOGAP), the only NAGAP chapter to focus on biomedical research graduate programs. At Einstein, Mr. Calabro is the director of graduate admissions and enrollment for the graduate division of biomedical sciences.

Thursday, May 24, 2018

Removing "Sick" from Sickle Cell Disease—The Doris Duke Charitable Foundation granted Eric Bouhassira, Ph.D., the 2017 Sickle Cell Disease/Advancing Cures Award, which funds clinical research that demonstrates potential to improve the quality of life of those suffering from sickle cell disease. More than 90,000 Americans are afflicted with sickle cell disease; dysfunctional red blood cells cause these individuals lifelong pain and organ damage, and shorten their life expectancy. Rather than treat symptoms, Dr. Bouhassira’s research targets the core of the disease. His approach involves removing blood-forming cells from patients, correcting the defective hemoglobin genes using DNA editing technology, and returning these cells to the patients. The method has been shown to restore red blood cell function. Dr. Bouhassira is a professor of cell biology and of medicine and is the Ingeborg and Ira Leon Rennert Professor of Stem Cell Biology and Regenerative Medicine.

Friday, May 11, 2018

Recognition of Excellence—The Anxiety and Depression Association of America (ADAA) awarded Simon Rego, Psy.D., the Jerilyn Ross Clinician Advocate Award at their annual meeting in Washington, D.C.. This award recognizes a mental health professional who demonstrates exemplary patient care and advocacy for those suffering from anxiety disorders. Dr. Rego specializes in assessing and treating anxiety and stress disorders using cognitive behavioral therapy. He also promotes mental health awareness and shares his expertise through media interviews, presentations, and workshops, as well as books he has written. Dr. Rego is associate professor of psychiatry and behavioral sciences at Einstein, and chief of psychology and director of psychology training in the department at Montefiore.

Monday, April 30, 2018

Delivering Science at the Vatican—Edward Reichman, M.D., delivered two talks at the fourth international conference Unite to Cure: A Global Health Care Initiative,” in Vatican City, on April 26 and 27, 2018. The conference theme was “How Science, Technology and 21st Century Medicine Will Impact Culture and Society,” and Dr. Reichman spoke at two symposia “The Culture of Life and Religious Influence on Health” and “Longevity and the Morality of Extreme Life Extension.” He is professor of emergency medicine, and of epidemiology & population health at Einstein. He also is in clinical practice, in emergency medicine, at Montefiore, and teaches Jewish medical ethics in the Einstein Bioethics Master’s Program.

Monday, April 30, 2018

Honor for Service—The Einstein Postdoctoral Association (EPA) elected Elena Martynova, Ph.D., to represent Einstein at the National Postdoctoral Association Conference this April, in Cleveland, Ohio. With more than 500 postdoctoral scholars, faculty, and industry representatives expected to attend, the conference is the largest in the nation at which postdocs can network and improve their professional and leadership skills. The EPA selects one postdoc annually to attend the conference with sponsorship provided by the Belfer Institute. The honor recognizes Dr. Martynova’s dedication to improving postdoctoral life through her participation in numerous campus groups, including the Quality of Life committee, the Senate Council committee, the Einstein Senate, and the EPA. Dr. Martynova is a postdoctoral fellow in the lab of Ales Cvekl, Ph.D., who is professor of ophthalmology & visual sciences and of genetics, the Max Berger Chair in Ophthalmology, and vice chair for research in of ophthalmology & visual sciences.

Monday, March 12, 2018

Innovative Recognition—The National Academy of Inventors (NAI) has elected William Jacobs, Jr., Ph.D., as an NAI fellow. The distinction recognizes his numerous accomplishments as an innovator in biomedical research and is the highest professional accolade bestowed to academic inventors. These include development of the shuttle plasmid for use in introducing foreign DNA into mycobacteria and establishment of dual-reporter and luciferase mycobacteriophages to rapidly diagnose drug-resistant tuberculosis. Dr. Jacobs’ research focuses on developing systems to genetically manipulate the Mycobacterium tuberculosis, the  causative agent of tuberculosis. In recent years there has been an alarming increase in the incidence of tuberculosis that is resistant to some or all of the drugs currently available. The World Health Organization has declared this a global health emergency. Dr. Jacobs’ lab currently aims to identify genes that play a key role in the virulence of M. tuberculosis, and which may prove to be effective targets for drug development. Dr. Jacobs is professor of microbiology & immunology and of genetics and holds the Leo and Julia Forchheimer Chair in Microbiology & Immunology at Einstein and has been a Howard Hughes Medical Institute investigator for the last 30 years. 

Monday, February 12, 2018

Rewarding Development—Nonalcoholic fatty liver disease (NAFLD) is the most common liver disorder in the United States. The Harrington Discovery Institute, in Cleveland, Ohio, has selected Victor Schuster, M.D., as a recipient of its 2018 Harrington Scholar-Innovator Award. Through support from the institute, awardees undertake innovative studies in diverse fields, ranging from cancer, diabetes, and liver disease, to osteoporosis and addiction, and are encouraged to develop products that could have commercial potential. The honor provides Dr. Schuster with a two-year grant supporting his efforts to develop a small molecule drug to mitigate and reverse nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Using funds from the award, Dr. Schuster and his team will investigate therapeutic potential of increasing the body’s level of cell communication molecules called prostaglandins in a preclinical mouse model of NAFLD. The goal of the study is to significantly improve treatment outcomes for NAFLD and liver fibrosis/cirrhosis treatment worldwide. Dr. Schuster is senior vice-dean, professor of medicine and of physiology and biophysics, and holds the Ted and Florence Baumritter Chair in Medicine.

Wednesday, January 31, 2018

Invited Keynote Address—The National Cancer Institute (NCI) and the American Society for Cell Biology (ASCB) have invited John Condeelis, Ph.D., to deliver the keynote address at their workshop “Imaging Subcellular to Cellular Cancer Biology,” on April 5, 2018, at the NIH Natcher Conference Center, in Bethesda, MD.  He will present “Multiphoton Intravital Imaging at Single Cell Resolution Reveals the Mechanism of Cancer Cell Dissemination and Metastasis.” Dr. Condeelis is a pioneer in study of the tumor microenvironment using multiphoton imaging techniques to understand the mechanisms that allow cancer to spread. His discoveries have been used by clinicians at Einstein-Montefiore in the clinical prognosis and treatment of breast cancer. He is professor and co-chair of anatomy & structural biology, as well as the Judith and Burton P. Resnick Chair in Translational Research. He also is co-director of the Gruss-Lipper Biophotonics Center and of the Integrated Imaging Program, scientific director of the Analytical Imaging Facility, and director of the Tumor Microenvironment and Metastasis Program, in the Albert Einstein Cancer Center.

Tuesday, January 30, 2018

Honor of Distinction—The Academy for Radiology & Biomedical Imaging Research presented its 2017 Distinguished Investigator Award to Michael Lipton, M.D., Ph.D., F.A.C.R. The honor recognizes individuals for their achievements in the field of biomedical imaging. Dr. Lipton’s research and clinical efforts using medical imaging have contributed significantly to detecting and characterizing mild brain injuries or concussion. His work on the adverse effects of soccer heading, even in the absence of concussion, has garnered international press attention.  His laboratory uses noninvasive methods to understand human cognition, behavior and functional abnormalities of the brain. Dr. Lipton is professor of radiology, of psychiatry and behavioral sciences, and in the Dominick P. Purpura Department of Neuroscience. He also is associate director of Einstein’s Gruss Magnetic Resonance Research Center, Director of Radiology Research and Medical Director of MRI Services at Montefiore.

Wednesday, January 24, 2018

Most Downloaded Article—A publication by Jill Crandall, M.D., and colleagues, titled, “Statin use and risk of developing diabetes: results from the Diabetes Prevention Program,” appearing in the October 1, 2017 issue of BMJ Open Diabetes Research & Care, is the journal’s most downloaded article of the year. Dr. Crandall’s study found that the use of statins —a class of drugs used to lower blood cholesterol—heightens the risk of type 2 diabetes (T2D) in susceptible individuals. It was already known that long-term use of statins increases the risk of T2D in patients at low risk for the disease by 10 to 12 percent. Dr. Crandall and colleagues looked at the incidence of T2D among 3,234 participants in the Diabetes Prevention Program —a population already at high risk for T2D— and found that statin use increased their T2D risk by close to 30 percent. The publication received coverage in U.S. News & World Report and was the subject of more than 500 tweets. Dr. Crandall is professor of medicine, director of the Diabetes Clinical Trials Unit, and an attending physician in medicine at Montefiore.

Tuesday, January 23, 2018
First Page | Previous Page | Page of 22 | Next Page | Last Page